Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Brds is not being diluted.
Float is being bought up by institutional investors and management.
I am expecting a huge very huge short squeeze soon.
Grabbed 34 thousand shares while its so cheap.
Next few weeks should be good.
GLTA!!
Approaching half a billion shares outstanding.
Even with such a good pipeline as soon as they get approval the stock will collapse.
Just like acer did.
It will get a small pump in May but everyone is waiting to sell apond approval.
Very heavily shorted tho.
80% held tight so a massive short squeeze could also take place .
But i would rule that out because the float is way too high.
Its a big gamble in or out .
No approval its game over.
Approaching half a billion shares outstanding.
Even with such a good pipeline as soon as they get approval the stock will collapse.
Just like acer did.
It will get a small pump in May but everyone is waiting to sell apond approval.
Very heavily shorted tho.
80% held tight so a massive short squeeze could also take place .
But i would rule that out because the float is way too high.
Its a big gamble in or out .
No approval its game over.
14,072,615 Shares of Common Stock
Warrants to Purchase up to 14,072,615 Shares of Common Stock
and
the Shares of Common Stock underlying the Warrants
We are offering 14,072,615 shares of our common stock, par value $0.0001 per share (the “common stock”), and warrants to purchase up to 14,072,615 shares of our common stock (and the shares of common stock issuable from time to time upon exercise of those warrants). Each share of common stock sold in this offering will be accompanied by a warrant to purchase one share of our common stock at an exercise price of $4.2636 per share. Each share of common stock and the accompanying warrant is being sold at a combined offering price of $3.5530. Subject to certain ownership limitations, the warrants will be immediately exercisable, and the warrants will expire two years after the initial issuance date. The shares of common stock and the warrants will be issued separately. We refer to the shares of common stock and the accompanying warrants, including the underlying shares of common stock, to be issued in this offering, collectively, as the “securities.”
2022 Top Story in Bladder Cancer: Use of N-803 With BCG in BCG-Unresponsive Non–Muscle Invasive Bladder Cancer
The final results from an open-label multicenter study (NCT03022825) examining the use of N-803 with BCG in patients with BCG-unresponsive non–muscle invasive bladder cancer were presented at ASCO in June and published in the Journal of Clinical Oncology.1
N-803, an IL-15 super agonist that activates natural killer cells and CD8+ T cells, was combined with BCG and tested in patients in two cohorts: group A (carcinoma in situ [CIS]) and group B (papillary disease).
A total of 160 patients (83 with CIS and 77 with papillary disease) were enrolled, and the median number of prior BCG doses was 12. Patients received intravesical N-803 with BCG using standard induction and maintenance dosing.
The authors reported results for each cohort. Among patients with CIS, 71% (59/83) had a complete response, with a median duration of 24 months in responders. There was a 96% 2-year bladder cancer–specific progression-free survival in muscle-invasive bladder cancer. For patients with papillary disease, 12-month and 24-month disease-free survival rates of 57% and 48% were noted. At 2 years of follow-up, a total of 90% had avoided cystectomy.
Treatment was well-tolerated. Low-grade treatment-related adverse events were reported, including dysuria (22%) and urgency (12%), and there were no grade 4 or 5 adverse events. No immune-related serious adverse events occurred.
In summary, for patients with BCG-unresponsive disease, N-803 plus BCG offers a safe, effective, and well-tolerated treatment option.
This study is significant because treating BCG-unresponsive disease is challenging and patients have limited options. Also, many patients may not be eligible for or wish to undergo cystectomy. This important study offers a new option that can provide a durable treatment alternative for patients with a life-threatening bladder cancer diagnosis.
Jmia short covering going on before they announce a new ceo more short covering to come.
GLTA!!!
Ibrx expect a big swing monday .
Up premarket down quick at the open then a recovery
around 10.15 always a drop at noon then upward to 3 then a drop around 3 15.
Got to love the day traders they are making me money so predictable.
Bought at 6.50 pershare up in shares and value because of the trade patterns.
Sell at market at open buy 15 mins later.
Vicious cycle and must be super observant .
Long term huge winner !!!
Also I like Jmia and Smmt
Huge sell off today .
Many drugs in phase 2 and 3.
Grabbed 2900 shares at 4.34 a gift.
Shorts are having a jolly good time but are blind folded at the moment.
They are all about to be stampeded by bulls soon.
90 % of shares are in strong hands.
Margin calls are going to kick in driving the pps up.
Any positive results from fda will cause a explosion in the pps.
Pharmaceutical stocks like ibrx are suicide to short with so many late stage drugs in the pipe line plus about 90% of the shares are tide up.
GLTA !!!
Last price 4.38 april 21.
Clock is ticking now.
Lots of advancements coming.
Graphite supplys are nearing record lows while demand is record highs.
Up 18% on the us side today markets will still be closed tomorrow on the canadian side.
On Wenesday if your thinking of getting in Do market order at the open.
Be quick tesla is securing all the grafite in north america the other 3 auto makers will want to secure deals with mason.
Its going to go crazy soon .
I got so many shares.
Its a win win if i sell 50 k of shares
I make money if it goes up my remaining shares make money if it goes down I am all over this stock...
I got in at .51 this is still very cheap
at .74.
I tell all my friends to buy yet no one did
I say its a very boring stock.
But steady as it goes...
All aboard...
Moves very slowly but its all good.
Steady as it goes.
Its all up hill from here .
A few other companies are trying to open mines in quebec but mason is years in advancement with all the permits in place
a brand new board of directors that actually give a dam.
The old board was just there it seems to collect a paycheck and give themselves options.
Every thing is green now its a go.
We will see a dollar very soon .
And rhat is still very very cheap.
We are on the edge of an explosion
in graphite demand.
My account is going up thousands everyday on this stock..
All aboard !!!
The one month graft is amazing something big is coming and I am locked and loaded.
Multi bagger coming soon .
Huge contracts from blackswan.
Going public soon.
Multi battery factories headed to Quebec.
Announcements to follow soon.
Next few weeks should be sweet for any investors that got in early.
GLTA !!
Blackswan should go public soon.
It will be a spinoff of mason.
All mason share holders should be entiled to shares based on thier holdings.
Lots of excitement brewing in this stock.
Very low volune pushing this stock higher and higher.
Any contract news will send mason to the moon.
Shares are tight.
Huge surge this week in the pps .
This is just the start
Black swan was purchased by Mason
Tesla was in talks with the quebec
Goverment to set up a mega battery
Factory in Quebec
Mason is about to explode.
Company is not profitable yet.
There will be many more offerings .
At a much lower price point .
Expansion cost money which the company doesn't have .
Sadly $4.00 a share is probaly it.
For a few years I just hope the shorts
don't pound this company into the ground.
Because they will be forced to do a reverse split if that happens then do more offerings to raise capital.
It's a buy at 1.75
Expect a few down grades next week .
I might be wrong but it appears to be headed that way .
No support of the stock from the company
Looks like a free fall to the 3.65 range
Company needs to support the stock
It's being walked down on very low volume.
Discouraging to all the longs.
Block Buster news is needed
Low float the shorts will get fried soon
So I think there's a big short squeeze
on the horizon.
Last price $7.03
Stock is getting hammard.
Shorts are having a field day .
I expect it to continue to go down.
Until earnings come out .
Very low volume could be a short squeeze soon.
No volume this is a gem.
When they announce a partnership or take over expect the stock to explode.
For now I will just add and wait.
Buying small lots when ever I can.
The price won't stay this low much longer.
Very low volume.
When news comes out watch easily an
25-200% increase.
Bid and ask are super thin .
Explosive run with the right news
adding slowly at these prices.
A million share float at $8.60
It's a good gamble the assets of the company and low float make this a no brainer.
Even a small order will drive the price Thu the roof .
Stock is heavily shorted any positive news exspecially a take over will send this stock to 60 in a flash.
Going to be interesting to see how the earnings will Effect the stock.
A lot of money went into the development of the corona vaccine .
They blew it.
By the time they get a vaccine they would have spent millions and it would be too late.
Ino is going to collapse then do a reverse split .
Just to stay on the nasdaq.
Shorts are going to have a field day.
Sad they were first in line with their trials.
They should scrape the vaccine research immediately.
Cut their loses and move on.
I could be wrong just my opinion..
Counter offer coming.
The reason why it shot up so fast on news is because the float is tiny.
The stock triggered the shorts to come out in full force today.
Millions of shares now exist thanks to phantom shares .
Very dangerous game for shorts to play with such a tiny float.
This will be very interesting to see how it plays out over the next few trading days.
If they go bankrupt stock goes up .
They can't do a reverse split they just issued shares to be in compliance with the Nasdaq to stay listed.
Shorts are fighting to push nakd brand into the ground.
Nakd might be bought out .
Shorts are screwed if they don't cover at this price. Hedge funds dumping company trying to raise money to survive selling shares into the market .
A partnership announcement buyout will send nakd Thu the roof
This is a risk rewards okay at .075-.08
Not much of a risk
Just bought into jagx
I will hold this position.
I had nvax over a thousand shares I bought around 4.25 then it went to $3.90
I hung onto it for about a month
got fed up and sold it .
Biggest mistake I ever made .
There should be a surge in price on Monday .
Looks like Trump getting the virus triggar
A lot of panic .
Testing kits will be more in demand then ever now.
Earrings coming out on the 11 the of November.
Codx is heavily shorted.
Expecting a 15% surge on Monday and expecting codx to hit new highs in November.
You need to buy in on the hype around November 5th earnings on the 11th
It hit _14.98 in mins then collapsed
Another pump and dump
A waiting game
I've seen huge runs on Vyon
in the past.
Loading time
Seems like very bad news stocks getting hammard premarket.
Just had to grab shares at .21
Don't ask me why I just had too
All Aboard :)
Timber see you all at .20